Articles Tagged With "merger"

Sanofi and Genzyme ready to post marriage banns?

After months of well publicized pre-marital squabbles, Sanofi-Aventis and Genzyme appear to be coming to terms with their differences and may even be ready to announce their impending nuptials. Like […]

Barnes & Noble and Borders Group: A Sears, Kmart Redux?

Today The New York Times DealBook asks the question: Does it make sense to combine two booksellers with eroding sales and growing competition from the likes of Amazon.com and now […]

Genzyme rejects Sanofi’s bear hug acquisition offer

After years of bold proclamations of independence, another biotech may be in the throes of an inevitable takeover. Faced with manufacturing troubles, FDA investigations, and struggles with shareholders, Genzyme has […]

Lofty Pfizer wipes out Wyeth

Many large pharmaceutical mergers over the years have resulted in fused identities: 1989: Bristol-Myers + Squibb = Bristol-Myers Squibb 1999: Zeneca + Astra = AstraZeneca 2000: Glaxo Wellcome + SmithKline Beecham […]

Intrigue in the data center (is IBM buying Sun?)

IBM and Sun Microsystems may get hitched. Meanwhile, Cisco Systems is moving in on both companies’ bread-and-butter in server computers.

How about some good news? Well, okay, some not-so-bad news.

The long-rumored merger between optical component suppliers Avanex and Bookham may finally happen. Get out the party hats!

Pfizer and Wyeth merger — could it be true (love)?

Reading stories about drug-making behemoth Pfizer these days has me humming the tune “perhaps, perhaps, perhaps …” The Wall Street Journal is reporting this morning that Pfizer is in talks […]

Bank of America struggles to digest Merrill Lynch

I heard there’s a new movie coming out called Confessions of a Shopaholic, a chick flick starring Kenneth Lewis playing a gal who just can’t say no. Of course, wacky […]

Will hostile takeovers become the norm for drugmakers?

Consolidation is a practical solution when the competitive squeeze gets put on an industry, and large pharmaceutical companies are predictably falling into the acquisitive suitor role in an effort to […]

Will Genentech take the Roche bait?

There’s a lot of speculation circulating about whether leading biotechnology firm Genentech will accept pharmaceutical giant Roche’s $43.7 billion takeover bid, the largest pharma/biotech merger price tag in several years. […]